Opportunity Information: Apply for CDC RFA DP12 1205
Apply for CDC RFA DP12 1205
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance 93.919 Cooperative Agreements for State Based Comprehensive Breast and Cervical Cancer Early Detection Programs.
- This funding opportunity was created on Feb 22, 2012 and posted on Jan 25, 2012.
- Applicants must submit their applications by Mar 26, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,097,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $9,000,000.00 in funding.
- The number of recipients for this funding is limited to 81 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Limited to grantees currently funded under CDC RFA DP07 703 Please see the Full Announcement to read Eligibility information
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations (Funding Opportunity Number CDC RFA DP12-1205) is a CDC cooperative agreement designed to help state, territorial, and tribal public health organizations modernize and reposition their cancer prevention and control infrastructure for the coming decade. Rather than creating an entirely new system, the opportunity is built around transitioning an already established and high-performing public health platform into updated roles and functions that better match emerging needs in cancer prevention, early detection, data use, and program efficiency. In practical terms, this grant is about strengthening how cancer programs are run, narrowing attention to the cancers that create the greatest burden, and making sure that interventions and screening approaches are organized, evidence-based, scalable, and measurable.
A central theme of the announcement is improving efficiency across program management and operations. CDC signals an expectation that funded programs will look for ways to reduce duplication, streamline administrative and operational workflows, and better coordinate across related cancer activities. The intent is to make cancer prevention and control programs easier to manage, more consistent in performance, and more cost-effective without reducing quality. This efficiency focus also implies stronger alignment among planning, implementation, evaluation, and data systems so that resources can be targeted where they have the greatest population-level impact.
Another major priority is concentrating efforts on high-burden cancers and using interventions that already have a strong evidence base and are ready for broad implementation. The FOA emphasizes scalable strategies, meaning approaches that can be expanded across communities and health systems rather than limited to small pilot projects. The expectation is that grantees will prioritize interventions with demonstrated effectiveness and the potential to reach large numbers of people, especially in populations experiencing higher cancer incidence, mortality, or barriers to care.
The opportunity also places strong emphasis on improving cancer screening delivery by moving away from purely opportunistic screening (screening that happens inconsistently or only when people seek care for other reasons) toward organized screening programs. Organized screening typically includes defined target populations, systematic outreach and invitation, standardized follow-up, quality assurance, and tracking across the screening continuum. CDC is signaling that more structured screening systems can improve effectiveness and efficiency by increasing appropriate screening uptake, ensuring timely diagnostic follow-up after abnormal results, and reducing gaps and inequities that often occur when screening depends on chance encounters with the health care system.
Maintaining high-quality cancer registries and expanding how registry data are used is another core goal. The FOA underscores that registries are not just for counting cases; they are essential tools for guiding prevention strategies, targeting screening initiatives, monitoring disparities, and evaluating whether programs are reducing cancer burden. The announcement highlights sustaining quality standards in cancer registry operations while also pushing for broader application of registry information in prevention planning and screening improvement. This reflects a shift from data collection alone toward more active public health use of cancer surveillance data.
Programmatically, the announcement indicates it will fund five components and will continue supporting and promoting enhancements to three major CDC cancer initiatives: the National Comprehensive Cancer Control Program (NCCCP), the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), and the National Program of Cancer Registries (NPCR). This positioning makes the FOA a kind of integrative continuation mechanism, encouraging coordination across comprehensive cancer control planning, organized screening delivery for breast and cervical cancer, and robust cancer surveillance capacity.
From an administrative standpoint, this is a continuation opportunity (Opportunity Category: Continuation) using a cooperative agreement funding instrument, which typically means CDC expects substantial involvement through technical assistance, collaboration on program strategy, and performance oversight. The activity category is health, with an estimated total funding amount of about $1.097 billion and an award ceiling listed at $9 million. The FOA anticipated 81 awards. There is no cost sharing or matching requirement noted in the source data.
Eligibility is limited. Applicants must be current grantees funded under CDC RFA DP07-703, meaning this announcement is not open competition for new entrants. It is specifically intended to transition and advance existing CDC-funded cancer prevention and control grantees into the next phase of work.
Key dates in the source information include a posted date of January 25, 2012, with an original and current closing date of March 26, 2012, and an archive date of April 25, 2012. For submission or access issues, the contact listed is the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS), with a general inquiries phone number of 770-488-2700.
Overall, the FOA is best understood as CDCs effort to evolve a mature national cancer control infrastructure by tightening operations, prioritizing the biggest drivers of cancer burden, building more systematic screening models, and using cancer registry data more strategically. The end goal is a more coordinated, data-driven, and scalable approach to cancer prevention and early detection across states, territories, and tribal organizations.
Frequently Asked Questions (FAQs)
What is the funding opportunity CDC RFA DP12-1205?
CDC RFA DP12-1205, titled "Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations," is a CDC cooperative agreement designed to help state, territorial, and tribal public health organizations modernize and reposition their cancer prevention and control infrastructure for the coming decade.
What is the overall goal of this cooperative agreement?
The goal is to strengthen how cancer programs are run by improving management and operations, focusing on cancers that create the greatest burden, and ensuring that interventions and screening approaches are organized, evidence-based, scalable, and measurable.
Is this opportunity building a brand-new cancer control system?
No. The opportunity is built around transitioning an already established and high-performing public health platform into updated roles and functions that better match emerging needs in cancer prevention, early detection, data use, and program efficiency.
What does CDC mean by "modernize and reposition" cancer prevention and control infrastructure?
Based on the announcement summary, it means updating the roles and functions of existing cancer prevention and control programs so they better align with current and emerging needs, including improved program efficiency, stronger use of data, and better-organized screening and interventions.
What are the main priorities emphasized in the announcement?
The announcement emphasizes: improving efficiency across program management and operations; concentrating efforts on high-burden cancers; using interventions with a strong evidence base that are ready for broad implementation; improving screening delivery by moving toward organized screening approaches; maintaining high-quality cancer registries; and expanding how registry data are used for prevention planning and screening improvement.
How does the FOA define the efficiency focus in program operations?
CDC signals an expectation that funded programs will reduce duplication, streamline administrative and operational workflows, and coordinate across related cancer activities. The intent is to make programs easier to manage, more consistent in performance, and more cost-effective without reducing quality.
Does the FOA require a focus on certain cancers?
Yes. A major priority is concentrating efforts on high-burden cancers and narrowing attention to the cancers that create the greatest burden.
What types of interventions does CDC want grantees to prioritize?
The FOA emphasizes interventions that already have a strong evidence base, have demonstrated effectiveness, are ready for broad implementation, and are scalable so they can be expanded across communities and health systems rather than limited to small pilot projects.
What does "scalable strategies" mean in this funding opportunity?
In this FOA, scalable strategies are approaches that can be expanded broadly across communities and health systems, with the potential to reach large numbers of people rather than staying limited to small pilots.
How does the FOA address cancer screening delivery?
The opportunity places strong emphasis on improving screening delivery by moving away from purely opportunistic screening toward organized screening programs.
What is the difference between opportunistic screening and organized screening, as described here?
Opportunistic screening is described as screening that happens inconsistently or only when people seek care for other reasons. Organized screening is described as having defined target populations, systematic outreach and invitation, standardized follow-up, quality assurance, and tracking across the screening continuum.
Why is CDC encouraging organized screening approaches?
CDC signals that more structured screening systems can improve effectiveness and efficiency by increasing appropriate screening uptake, ensuring timely diagnostic follow-up after abnormal results, and reducing gaps and inequities that can occur when screening depends on chance encounters with the health care system.
What is the role of cancer registries in this FOA?
Maintaining high-quality cancer registries and expanding how registry data are used is a core goal. The FOA underscores that registries are essential tools for guiding prevention strategies, targeting screening initiatives, monitoring disparities, and evaluating whether programs are reducing cancer burden.
Is the FOA focused only on collecting registry data?
No. The announcement highlights sustaining quality standards in registry operations while pushing for broader and more active public health use of cancer surveillance data in prevention planning and screening improvement.
How many components will this FOA fund?
The announcement indicates it will fund five components.
Which CDC cancer initiatives are supported and enhanced under this opportunity?
The FOA will continue supporting and promoting enhancements to three major CDC cancer initiatives: the National Comprehensive Cancer Control Program (NCCCP), the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), and the National Program of Cancer Registries (NPCR).
What is the Opportunity Category for this announcement?
The source information lists the Opportunity Category as Continuation.
What type of funding instrument is used?
This announcement uses a cooperative agreement funding instrument.
What does it mean that this is a cooperative agreement?
The summary notes that a cooperative agreement typically means CDC expects substantial involvement through technical assistance, collaboration on program strategy, and performance oversight.
What is the Activity Category for this opportunity?
The activity category is listed as Health.
How much funding is available in total?
The estimated total funding amount is about $1.097 billion.
What is the maximum award amount per award?
The award ceiling is listed at $9 million.
How many awards were anticipated?
The FOA anticipated 81 awards.
Is cost sharing or matching required?
No cost sharing or matching requirement is noted in the source data provided.
Who is eligible to apply?
Eligibility is limited to current grantees funded under CDC RFA DP07-703. This announcement is not open competition for new entrants.
Is this opportunity open to organizations that were not funded under DP07-703?
No. Based on the information provided, applicants must be current grantees funded under CDC RFA DP07-703.
What kinds of organizations is this designed to support?
It is designed to support state, territorial, and tribal public health organizations in modernizing and repositioning their cancer prevention and control infrastructure.
When was the opportunity posted and when did it close?
The posted date is January 25, 2012. The original and current closing date is March 26, 2012.
Is this opportunity archived?
Yes. The archive date listed is April 25, 2012.
Who is the listed contact for submission or access issues?
The contact listed is the CDC Procurement and Grants Office (PGO), Technical Information and Management Section (TIMS). The general inquiries phone number provided is 770-488-2700.
What is the end goal of this FOA, based on the description provided?
The end goal is a more coordinated, data-driven, and scalable approach to cancer prevention and early detection across states, territories, and tribal organizations by tightening operations, prioritizing the biggest drivers of cancer burden, building more systematic screening models, and using cancer registry data more strategically.
Browse more opportunities from the same category: Health
Next opportunity: Learning Disabilities Innovation Hubs (R24)
Previous opportunity: National Maternal and Child Health Data Resource Center Cooperative Agreement Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP12 1205
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP12 1205) also looked into and applied for these:
| Funding Opportunity |
|---|
| Drug Free Communities Support Program Apply for SP 12 001 Funding Number: SP 12 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Building the Institutional Capacity of Local Indigenous Organizations Implementing Comprehensive Clinical and Laboratory Services to Sustain and Enhance the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under PEPFAR Apply for CDC RFA GH12 1230 Funding Number: CDC RFA GH12 1230 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Implementing Evidence Based Prevention Interventions to Prevent New HIV Infections in the United Republic of Tanzania Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1236 Funding Number: CDC RFA GH12 1236 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $540,000 |
| Interventions to Improve HIV/AIDS and Alcohol Related Outcomes (U01) Apply for RFA AA 12 009 Funding Number: RFA AA 12 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Competing Revisions for Macromolecular Interactions in Cells (R01) Apply for RFA GM 13 003 Funding Number: RFA GM 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $80,000 |
| USAID/Uganda Therapeutic and Supplementary Products for Improved Nutrition (TASPIN) Apply for RFA 617 12 000002 Funding Number: RFA 617 12 000002 Agency: Uganda USAID Kampala Category: Health Funding Amount: $22,000,000 |
| Rapid Response to Requests for Rural Data Analysis and Issue Specific Rural Research Studies Apply for HRSA 12 090 Funding Number: HRSA 12 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Information Services to Rural Hospital Flexibility Grantees Program Cooperative Agreement (Technical Assistance Center) Apply for HRSA 12 098 Funding Number: HRSA 12 098 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Leadership Group for a Clinical Research Network on Vaccines to Prevent HIV infection (UM1) Apply for RFA AI 12 012 Funding Number: RFA AI 12 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Claude D. Pepper Older Americans Independence Centers (OAICs) and Coordinating Center (P30) Apply for RFA AG 13 002 Funding Number: RFA AG 13 002 Agency: National Institutes of Health Category: Health Funding Amount: $175,000 |
| NIBIB Research Education Programs for Residents and Clinical Fellows (R25) Apply for PAR 12 085 Funding Number: PAR 12 085 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Support For HIV/AIDS Population Based Surveys And Statistical Capacity Building In Zambia Apply for CDC RFA GH12 1246 Funding Number: CDC RFA GH12 1246 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Strengthening Laboratory Infrastructure, Quality of Laboratory Services, and Strategic Information Capacity in the Federal Democratic Republic of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1219 Funding Number: CDC RFA GH12 1219 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,276,624 |
| Support Uganda Ministry of Health Capacity to Address HIV and Other Health Priority Conditions through Strengthening Health Systems Under the Presidents Emergency Plan for AIDs Relief Apply for CDC RFA GH12 1216 Funding Number: CDC RFA GH12 1216 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,586,824 |
| Expanding Participation of People with Disabilities Apply for RFA 176 12 000003 Funding Number: RFA 176 12 000003 Agency: Kazakhstan USAID Almaty Category: Health Funding Amount: $600,000 |
| Medical Monitoring Project Apply for CDC RFA PS09 93704CONT12 Funding Number: CDC RFA PS09 93704CONT12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Marketing Innovation For Health Apply for RFA 388 12 000001 Funding Number: RFA 388 12 000001 Agency: Bangladesh USAID Dhaka Category: Health Funding Amount: $15,000,000 |
| Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Coordinating and Statistical Centers (U01) Apply for RFA NS 13 001 Funding Number: RFA NS 13 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Clinical Sites (U10) Apply for RFA NS 13 002 Funding Number: RFA NS 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource support for Consortiums for HIV/AIDS and Alcohol Related Outcomes Research Trials (CHAART) U24 Apply for RFA AA 12 010 Funding Number: RFA AA 12 010 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP12 1205", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.